Christina Yee, M.D., Ph.D.
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name | Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Desensitization, Immunologic | 6 | 2020 | 483 | 1.530 |
Why?
|
| Urticaria | 2 | 2019 | 150 | 1.200 |
Why?
|
| Allergens | 3 | 2018 | 1314 | 1.100 |
Why?
|
| Clindamycin | 1 | 2018 | 139 | 0.610 |
Why?
|
| Anti-Allergic Agents | 1 | 2018 | 141 | 0.590 |
Why?
|
| Peanut Hypersensitivity | 1 | 2018 | 163 | 0.560 |
Why?
|
| Acetaminophen | 1 | 2020 | 544 | 0.550 |
Why?
|
| Anaphylaxis | 3 | 2018 | 746 | 0.550 |
Why?
|
| Cold Temperature | 1 | 2018 | 774 | 0.510 |
Why?
|
| Drug Hypersensitivity | 2 | 2020 | 883 | 0.440 |
Why?
|
| Homozygote | 2 | 2021 | 1777 | 0.420 |
Why?
|
| Cytoskeleton | 1 | 2015 | 1185 | 0.370 |
Why?
|
| Protein Multimerization | 1 | 2015 | 971 | 0.370 |
Why?
|
| Virus Diseases | 2 | 2015 | 710 | 0.370 |
Why?
|
| Microfilament Proteins | 1 | 2015 | 1152 | 0.360 |
Why?
|
| Food Hypersensitivity | 1 | 2016 | 622 | 0.330 |
Why?
|
| Neutrophils | 1 | 2020 | 3711 | 0.310 |
Why?
|
| Trans-Activators | 3 | 2005 | 2924 | 0.270 |
Why?
|
| Cathepsin E | 1 | 2004 | 3 | 0.250 |
Why?
|
| Fluorescein-5-isothiocyanate | 1 | 2005 | 225 | 0.250 |
Why?
|
| Nuclear Proteins | 4 | 2015 | 5851 | 0.240 |
Why?
|
| Histocompatibility Antigens Class II | 2 | 2005 | 1470 | 0.230 |
Why?
|
| Respiratory Burst | 1 | 2020 | 113 | 0.180 |
Why?
|
| Congenital Disorders of Glycosylation | 1 | 2020 | 45 | 0.180 |
Why?
|
| Rhodamines | 1 | 2020 | 183 | 0.180 |
Why?
|
| Anti-Bacterial Agents | 1 | 2018 | 7153 | 0.180 |
Why?
|
| Administration, Oral | 2 | 2018 | 3913 | 0.170 |
Why?
|
| Interleukin-10 | 1 | 2005 | 1200 | 0.170 |
Why?
|
| Glycocalyx | 1 | 2020 | 88 | 0.170 |
Why?
|
| Bee Venoms | 1 | 2018 | 14 | 0.170 |
Why?
|
| Up-Regulation | 2 | 2005 | 4211 | 0.160 |
Why?
|
| T-Lymphocyte Subsets | 2 | 2018 | 1837 | 0.160 |
Why?
|
| Insect Bites and Stings | 1 | 2018 | 67 | 0.160 |
Why?
|
| Indolizines | 1 | 1997 | 37 | 0.160 |
Why?
|
| GTPase-Activating Proteins | 1 | 2021 | 497 | 0.160 |
Why?
|
| Cefazolin | 1 | 2018 | 96 | 0.150 |
Why?
|
| Mutation | 3 | 2018 | 29717 | 0.150 |
Why?
|
| Skin Tests | 1 | 2018 | 612 | 0.140 |
Why?
|
| Hypersensitivity, Immediate | 1 | 2018 | 334 | 0.130 |
Why?
|
| Carboplatin | 1 | 1998 | 799 | 0.130 |
Why?
|
| Warts | 1 | 2015 | 68 | 0.130 |
Why?
|
| Pruritus | 1 | 2018 | 359 | 0.130 |
Why?
|
| Cell Degranulation | 1 | 2015 | 287 | 0.120 |
Why?
|
| Pedigree | 3 | 2021 | 4646 | 0.120 |
Why?
|
| Granulomatous Disease, Chronic | 1 | 2015 | 174 | 0.120 |
Why?
|
| Dendritic Cells | 2 | 2005 | 2723 | 0.120 |
Why?
|
| Child | 9 | 2021 | 77478 | 0.120 |
Why?
|
| Immunomodulation | 1 | 2018 | 540 | 0.120 |
Why?
|
| Edema | 1 | 2018 | 790 | 0.120 |
Why?
|
| Withholding Treatment | 1 | 2018 | 598 | 0.120 |
Why?
|
| Frameshift Mutation | 1 | 2015 | 399 | 0.120 |
Why?
|
| Exanthema | 1 | 2018 | 488 | 0.110 |
Why?
|
| Lymphocyte Count | 1 | 2015 | 792 | 0.110 |
Why?
|
| Lymphopenia | 1 | 2015 | 285 | 0.110 |
Why?
|
| Severe Combined Immunodeficiency | 1 | 2015 | 221 | 0.110 |
Why?
|
| Cell Death | 1 | 1998 | 1695 | 0.110 |
Why?
|
| Lung Diseases, Interstitial | 1 | 2021 | 807 | 0.110 |
Why?
|
| Flow Cytometry | 3 | 2020 | 5975 | 0.110 |
Why?
|
| Immunoglobulin E | 1 | 2018 | 1460 | 0.110 |
Why?
|
| Immunoglobulins | 1 | 2015 | 880 | 0.100 |
Why?
|
| Pharmaceutical Preparations | 1 | 2020 | 1071 | 0.100 |
Why?
|
| Cell Survival | 3 | 2015 | 5872 | 0.100 |
Why?
|
| Lymphoma, Large-Cell, Anaplastic | 1 | 2013 | 169 | 0.100 |
Why?
|
| Immunologic Deficiency Syndromes | 1 | 2015 | 546 | 0.100 |
Why?
|
| Calcium Channels | 1 | 2015 | 621 | 0.100 |
Why?
|
| Autoantigens | 1 | 2015 | 891 | 0.100 |
Why?
|
| Siblings | 1 | 2015 | 854 | 0.100 |
Why?
|
| Cell Cycle | 1 | 1998 | 2964 | 0.090 |
Why?
|
| Protein Transport | 1 | 2015 | 1988 | 0.090 |
Why?
|
| Antigen Presentation | 2 | 2005 | 1284 | 0.080 |
Why?
|
| Autoantibodies | 2 | 2015 | 2036 | 0.080 |
Why?
|
| Actins | 1 | 2015 | 2120 | 0.080 |
Why?
|
| Adolescent | 5 | 2018 | 85649 | 0.080 |
Why?
|
| Endothelial Cells | 1 | 2020 | 3455 | 0.070 |
Why?
|
| Cytokines | 3 | 2015 | 7317 | 0.070 |
Why?
|
| Down-Regulation | 2 | 2005 | 3001 | 0.070 |
Why?
|
| T-Lymphocytes | 2 | 2015 | 10163 | 0.070 |
Why?
|
| Skin Diseases | 1 | 2015 | 1065 | 0.070 |
Why?
|
| Humans | 21 | 2021 | 742088 | 0.070 |
Why?
|
| DNA Mutational Analysis | 1 | 2015 | 4187 | 0.070 |
Why?
|
| Combined Modality Therapy | 1 | 2018 | 8621 | 0.070 |
Why?
|
| Immunoconjugates | 1 | 2013 | 897 | 0.070 |
Why?
|
| Homeodomain Proteins | 1 | 2015 | 2417 | 0.070 |
Why?
|
| Thrombosis | 1 | 2020 | 2966 | 0.070 |
Why?
|
| Enzyme Repression | 1 | 2004 | 32 | 0.060 |
Why?
|
| Fibroblasts | 1 | 2015 | 4143 | 0.060 |
Why?
|
| CD4-Positive T-Lymphocytes | 2 | 2015 | 4379 | 0.060 |
Why?
|
| T-Lymphocytes, Regulatory | 1 | 2018 | 2986 | 0.060 |
Why?
|
| Enzyme Precursors | 1 | 2004 | 176 | 0.060 |
Why?
|
| Transfection | 3 | 2015 | 5892 | 0.060 |
Why?
|
| Vaccinia virus | 1 | 2005 | 349 | 0.060 |
Why?
|
| Child, Preschool | 4 | 2020 | 40955 | 0.060 |
Why?
|
| Female | 10 | 2021 | 379592 | 0.060 |
Why?
|
| E1A-Associated p300 Protein | 1 | 2004 | 131 | 0.060 |
Why?
|
| Autoimmune Diseases | 1 | 2015 | 2130 | 0.060 |
Why?
|
| B-Lymphocyte Subsets | 1 | 2005 | 246 | 0.060 |
Why?
|
| Male | 13 | 2021 | 349538 | 0.060 |
Why?
|
| Mice | 6 | 2021 | 81045 | 0.060 |
Why?
|
| Dextrans | 1 | 2005 | 592 | 0.050 |
Why?
|
| Immunotherapy | 1 | 2018 | 4414 | 0.050 |
Why?
|
| Cell Line, Transformed | 1 | 2004 | 898 | 0.050 |
Why?
|
| Mice, Knockout | 3 | 2014 | 14554 | 0.050 |
Why?
|
| Ovalbumin | 1 | 2004 | 719 | 0.050 |
Why?
|
| Infant | 3 | 2020 | 35070 | 0.050 |
Why?
|
| Retroviridae | 1 | 2005 | 914 | 0.050 |
Why?
|
| Animals | 11 | 2021 | 168561 | 0.050 |
Why?
|
| Tumor Cells, Cultured | 3 | 1999 | 6313 | 0.050 |
Why?
|
| Disease Progression | 1 | 2018 | 13256 | 0.050 |
Why?
|
| Transduction, Genetic | 1 | 2005 | 913 | 0.050 |
Why?
|
| Paclitaxel | 2 | 1999 | 1707 | 0.050 |
Why?
|
| Hypertension | 1 | 2021 | 8455 | 0.050 |
Why?
|
| Myelin Proteolipid Protein | 1 | 2001 | 107 | 0.050 |
Why?
|
| DNA-Binding Proteins | 2 | 2015 | 9639 | 0.050 |
Why?
|
| Immunotherapy, Active | 1 | 2001 | 60 | 0.050 |
Why?
|
| Prostatic Neoplasms | 3 | 1999 | 11039 | 0.050 |
Why?
|
| Callithrix | 1 | 2001 | 93 | 0.050 |
Why?
|
| Severity of Illness Index | 1 | 2018 | 15530 | 0.050 |
Why?
|
| Caspases | 2 | 2001 | 928 | 0.050 |
Why?
|
| Lymphocytosis | 1 | 2021 | 119 | 0.050 |
Why?
|
| CpG Islands | 1 | 2005 | 1170 | 0.050 |
Why?
|
| Clinical Trials as Topic | 1 | 2016 | 7901 | 0.050 |
Why?
|
| rhoA GTP-Binding Protein | 1 | 2021 | 241 | 0.050 |
Why?
|
| Leukocytosis | 1 | 2021 | 247 | 0.050 |
Why?
|
| Immunodominant Epitopes | 1 | 2001 | 267 | 0.040 |
Why?
|
| Adenocarcinoma | 1 | 1997 | 6347 | 0.040 |
Why?
|
| Genes, Tumor Suppressor | 1 | 2004 | 1097 | 0.040 |
Why?
|
| Isoenzymes | 1 | 2004 | 1725 | 0.040 |
Why?
|
| Bees | 1 | 2018 | 43 | 0.040 |
Why?
|
| Spleen | 1 | 2005 | 2359 | 0.040 |
Why?
|
| Infant, Newborn | 1 | 2018 | 25575 | 0.040 |
Why?
|
| Dendrites | 1 | 2001 | 485 | 0.040 |
Why?
|
| Phenotype | 1 | 2015 | 16331 | 0.040 |
Why?
|
| Fibrin Fibrinogen Degradation Products | 1 | 2020 | 425 | 0.040 |
Why?
|
| S Phase | 1 | 1998 | 423 | 0.040 |
Why?
|
| Lipopolysaccharides | 1 | 2005 | 2211 | 0.040 |
Why?
|
| Retrospective Studies | 3 | 2020 | 77098 | 0.040 |
Why?
|
| Quality of Life | 1 | 2018 | 12730 | 0.040 |
Why?
|
| Membrane Proteins | 1 | 2014 | 7873 | 0.040 |
Why?
|
| Bone Marrow Cells | 1 | 2005 | 2513 | 0.040 |
Why?
|
| Cell Differentiation | 1 | 2014 | 11470 | 0.040 |
Why?
|
| Time Factors | 1 | 2018 | 40054 | 0.040 |
Why?
|
| Plasma | 1 | 2020 | 575 | 0.040 |
Why?
|
| Mice, Inbred C57BL | 2 | 2005 | 21821 | 0.030 |
Why?
|
| Capillary Permeability | 1 | 2020 | 798 | 0.030 |
Why?
|
| Brugia malayi | 1 | 1995 | 5 | 0.030 |
Why?
|
| Wuchereria bancrofti | 1 | 1995 | 20 | 0.030 |
Why?
|
| Filariasis | 1 | 1995 | 28 | 0.030 |
Why?
|
| Promoter Regions, Genetic | 2 | 2005 | 5867 | 0.030 |
Why?
|
| Antigens, Helminth | 1 | 1995 | 64 | 0.030 |
Why?
|
| HeLa Cells | 2 | 1999 | 3127 | 0.030 |
Why?
|
| Antineoplastic Agents, Phytogenic | 1 | 1999 | 623 | 0.030 |
Why?
|
| Cell Line | 3 | 2005 | 15994 | 0.030 |
Why?
|
| Signal Transduction | 3 | 2015 | 23387 | 0.030 |
Why?
|
| Cell Membrane | 1 | 2005 | 3744 | 0.030 |
Why?
|
| Epinephrine | 1 | 2018 | 793 | 0.030 |
Why?
|
| Apoptosis | 3 | 2001 | 9715 | 0.030 |
Why?
|
| Necrosis | 1 | 1998 | 1643 | 0.030 |
Why?
|
| Treatment Outcome | 2 | 2018 | 62966 | 0.030 |
Why?
|
| Ion Transport | 1 | 2015 | 320 | 0.030 |
Why?
|
| Tetradecanoylphorbol Acetate | 1 | 2015 | 821 | 0.030 |
Why?
|
| Gene Expression | 2 | 2018 | 7790 | 0.030 |
Why?
|
| Antibody Specificity | 1 | 2015 | 1094 | 0.030 |
Why?
|
| Consanguinity | 1 | 2015 | 456 | 0.030 |
Why?
|
| Immunophenotyping | 1 | 2018 | 1866 | 0.030 |
Why?
|
| Mice, Inbred Strains | 1 | 2015 | 1827 | 0.030 |
Why?
|
| DEAD-box RNA Helicases | 1 | 2015 | 375 | 0.030 |
Why?
|
| Toll-Like Receptors | 1 | 2015 | 592 | 0.030 |
Why?
|
| Phagocytosis | 1 | 1997 | 1538 | 0.030 |
Why?
|
| Multiprotein Complexes | 1 | 2018 | 1119 | 0.030 |
Why?
|
| Proto-Oncogene Proteins | 1 | 2004 | 4553 | 0.020 |
Why?
|
| Peptide Fragments | 1 | 2004 | 5095 | 0.020 |
Why?
|
| Adult | 4 | 2020 | 213712 | 0.020 |
Why?
|
| Lymphocyte Activation | 2 | 2018 | 5519 | 0.020 |
Why?
|
| Immunoblotting | 1 | 2014 | 1683 | 0.020 |
Why?
|
| Neoplasm Invasiveness | 1 | 1997 | 3612 | 0.020 |
Why?
|
| Receptors, Antigen, T-Cell | 1 | 2018 | 2524 | 0.020 |
Why?
|
| Cells, Cultured | 1 | 2005 | 19223 | 0.020 |
Why?
|
| RNA, Messenger | 1 | 2004 | 13029 | 0.020 |
Why?
|
| Cell Line, Tumor | 1 | 2004 | 16665 | 0.020 |
Why?
|
| Endothelium, Vascular | 1 | 2020 | 4455 | 0.020 |
Why?
|
| Neoplasm Metastasis | 1 | 1997 | 4839 | 0.020 |
Why?
|
| Microscopy, Fluorescence | 1 | 2014 | 2699 | 0.020 |
Why?
|
| Uterine Cervical Neoplasms | 1 | 1998 | 2011 | 0.020 |
Why?
|
| Multiple Sclerosis | 1 | 2001 | 3076 | 0.020 |
Why?
|
| HEK293 Cells | 1 | 2015 | 4200 | 0.020 |
Why?
|
| Antibodies, Neutralizing | 1 | 2015 | 1970 | 0.020 |
Why?
|
| Protein Binding | 1 | 2018 | 9387 | 0.020 |
Why?
|
| Proto-Oncogene Proteins c-akt | 1 | 2014 | 2502 | 0.020 |
Why?
|
| Analysis of Variance | 1 | 2014 | 6365 | 0.020 |
Why?
|
| Glutamate Decarboxylase | 1 | 2005 | 246 | 0.020 |
Why?
|
| Phosphorylation | 1 | 2014 | 8436 | 0.010 |
Why?
|
| DNA, Complementary | 1 | 2005 | 2049 | 0.010 |
Why?
|
| Antigen-Presenting Cells | 1 | 2005 | 969 | 0.010 |
Why?
|
| Disease Models, Animal | 2 | 2015 | 18006 | 0.010 |
Why?
|
| Rats | 1 | 1997 | 24265 | 0.010 |
Why?
|
| Dose-Response Relationship, Immunologic | 1 | 2001 | 370 | 0.010 |
Why?
|
| Immunohistochemistry | 1 | 2014 | 11363 | 0.010 |
Why?
|
| Cyclin B1 | 1 | 1999 | 52 | 0.010 |
Why?
|
| Cyclin B | 1 | 1999 | 108 | 0.010 |
Why?
|
| Cell Proliferation | 1 | 2015 | 10472 | 0.010 |
Why?
|
| Luciferases | 1 | 2001 | 733 | 0.010 |
Why?
|
| Injections, Intravenous | 1 | 2001 | 1420 | 0.010 |
Why?
|
| Electrophoresis, Polyacrylamide Gel | 1 | 2001 | 1801 | 0.010 |
Why?
|
| Young Adult | 2 | 2015 | 56350 | 0.010 |
Why?
|
| Dose-Response Relationship, Drug | 2 | 2001 | 10943 | 0.010 |
Why?
|
| Antibodies, Monoclonal | 1 | 2014 | 9274 | 0.010 |
Why?
|
| Sequence Homology, Amino Acid | 1 | 2001 | 2837 | 0.010 |
Why?
|
| Protein Isoforms | 1 | 2001 | 1727 | 0.010 |
Why?
|
| Recombinant Proteins | 1 | 2005 | 6608 | 0.010 |
Why?
|
| Th1 Cells | 1 | 2001 | 1056 | 0.010 |
Why?
|
| Th2 Cells | 1 | 2001 | 1049 | 0.010 |
Why?
|
| Plasmids | 1 | 2001 | 2305 | 0.010 |
Why?
|
| Exons | 1 | 2001 | 2431 | 0.010 |
Why?
|
| Transcriptional Activation | 1 | 2001 | 1782 | 0.010 |
Why?
|
| Antibody-Dependent Cell Cytotoxicity | 1 | 1995 | 304 | 0.010 |
Why?
|
| Base Sequence | 1 | 2005 | 12797 | 0.010 |
Why?
|
| Protein Structure, Tertiary | 1 | 2001 | 3847 | 0.010 |
Why?
|
| Reverse Transcriptase Polymerase Chain Reaction | 1 | 2001 | 4751 | 0.010 |
Why?
|
| Blotting, Western | 1 | 2001 | 5180 | 0.010 |
Why?
|
| Drug Administration Schedule | 1 | 2001 | 4929 | 0.010 |
Why?
|
| B-Lymphocytes | 1 | 2005 | 4664 | 0.010 |
Why?
|
| NF-kappa B | 1 | 2001 | 2500 | 0.010 |
Why?
|
| Recombinant Fusion Proteins | 1 | 2001 | 3770 | 0.010 |
Why?
|
| Cell Nucleus | 1 | 2001 | 2968 | 0.010 |
Why?
|
| Models, Genetic | 1 | 2001 | 3493 | 0.010 |
Why?
|
| Amino Acid Sequence | 1 | 2001 | 13814 | 0.010 |
Why?
|
| Epitopes | 1 | 1995 | 2569 | 0.010 |
Why?
|
| Cell Cycle Proteins | 1 | 1999 | 3444 | 0.000 |
Why?
|
| Immunosuppressive Agents | 1 | 2001 | 4147 | 0.000 |
Why?
|
| Molecular Sequence Data | 1 | 2001 | 18112 | 0.000 |
Why?
|
| DNA | 1 | 2001 | 7289 | 0.000 |
Why?
|
| Transcription, Genetic | 1 | 2001 | 7721 | 0.000 |
Why?
|
| Brain | 1 | 2001 | 26343 | 0.000 |
Why?
|
| Magnetic Resonance Imaging | 1 | 2001 | 35342 | 0.000 |
Why?
|